Your browser doesn't support javascript.
loading
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
Nooka, Ajay K; Kaufman, Jonathan L; Rodriguez, Cesar; Jakubowiak, Andrzej; Efebera, Yvonne; Reeves, Brandi; Wildes, Tanya; Holstein, Sarah A; Anderson, Larry D; Badros, Ashraf; Shune, Leyla; Chari, Ajai; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Bartlett, J Blake; Vermeulen, Jessica; Lin, Thomas S; Richardson, Paul G; Voorhees, Peter.
Afiliación
  • Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA. anooka@emory.edu.
  • Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Rodriguez C; Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
  • Efebera Y; OhioHealth, Columbus, OH, USA.
  • Reeves B; University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
  • Wildes T; Cancer & Aging Research Group, St. Louis, MO, USA.
  • Holstein SA; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Anderson LD; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
  • Badros A; Greenbaum Cancer Center, University of Maryland, Baltimore, MD, USA.
  • Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
  • Chari A; Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA.
  • Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Cortoos A; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Patel S; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Bartlett JB; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Vermeulen J; Janssen Research & Development, LLC, Leiden, the Netherlands.
  • Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Voorhees P; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Blood Cancer J ; 12(4): 63, 2022 04 13.
Article en En | MEDLINE | ID: mdl-35418120
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos